Crescent Biopharma, Inc.CBIONASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank79
3Y CAGR+424.9%
5Y CAGR+1.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+424.9%/yr
Annual compound
5Y CAGR
+1.3%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$10.84M-
2024$0.00-100.0%
2023$10000.00-86.7%
2022$75000.00-93.5%
2021$1.16M-88.6%
2020$10.16M-
2019$0.00-
2018$0.00-
2017$0.00-100.0%
2016$18500.00-